Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Peninsula spin-off Cerexa gets $50mm with financing

Executive Summary

Antibiotics company Cerexa brought in $50mm with its first financing round led by Frazier Healthcare Ventures and New Leaf Venture Partners. Also participating were existing backers AM Pappas & Associates, Canaan Partners, CDIB BioScience Ventures, Domain Associates, EGS Heathcare Capital, Montreux Equity Partners, and OrbiMed Advisors.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Spin-Off
    • Venture Financing

Related Companies